...
机译:用Rivaroxaban在地图集-ACS 2 Timi 51治疗急性冠状动脉综合征患者支架血栓形成的降低
Department of Medicine Beth Israel Deaconess Medical Center Harvard Medical School 185 Pilgrim;
Department of Medicine Beth Israel Deaconess Medical Center Harvard Medical School 185 Pilgrim;
Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA United;
Department of Cardiology and Angiology University of Freiburg Freiburg Germany;
University Hospital Jean Minjoz Besan?on France;
OnzeLieveVrouweGasthuis Amsterdam Netherlands;
Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA United;
Department of Medicine (Cardiology) Tokai University School of Medicine Isehara Japan;
Division of Cardiology Newark Beth Israel Medical Center Newark NJ United States;
Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA United;
Janssen Research and Development Titusville NJ United States;
Columbia University New York NY United States;
Department of Medicine Beth Israel Deaconess Medical Center Harvard Medical School 185 Pilgrim;
acute coronary syndrome(s); factor Xa inhibitor; rivaroxaban; stent thrombosis;
机译:用Rivaroxaban在地图集-ACS 2 Timi 51治疗急性冠状动脉综合征患者支架血栓形成的降低
机译:利伐沙班治疗ATLAS-ACS 2可减轻急性冠脉综合征患者的支架血栓形成2 TIMI 51
机译:在TRITON-TIMI 38试验中,通过口服经皮冠状动脉介入治疗和支架置入术,对减少急性缺血性事件(包括急性冠脉综合征的患者的支架血栓形成)进行强化口服抗血小板治疗:一项随机试验的亚分析。
机译:患有急性冠状动脉综合征(ACS)和糖尿病(DM)的患者,具有颅内骨折(一年观察)
机译:明确可能的急性冠脉综合征合并中度狭窄和高风险斑块形态的冠状动脉计算机断层扫描血管造影的最佳管理策略
机译:稳定的急性冠脉综合征患者在阿司匹林单药治疗中加用利伐沙班的安全性和有效性:ATLAS ACS-TIMI 46和ATLAS ACS 2-TIMI 51的汇总分析研究
机译:利伐沙班治疗ATLAS-ACS 2急性冠脉综合征患者的支架血栓减少2 TIMI 51